Prostate Cancer - Results from #820

Robust, credible, and interpretable AI-based histopathological prostate cancer grading. July 25, 2024

Enhancing Prostate Cancer Diagnosis: AI-Driven Virtual Biopsy for Optimal MRI-Targeted Biopsy Approach and Gleason Grading Strategy. July 25, 2024

Prostate cancers with distinct transcriptional programs in Black and White men. July 25, 2024

Prostate MRI for the detection of clinically significant prostate cancer: Update and future directions. July 24, 2024

Prostate cancer in transgender women: A propensity score-matched analysis of disease severity and survival. July 24, 2024

Optimising the use of the prostate- specific antigen blood test in asymptomatic men for early prostate cancer detection in primary care: report from a UK clinical consensus. July 24, 2024

Risk of Cancer-related Death for Men with Biopsy Grade Group 1 Prostate Cancer and High-risk Features: A European Multi-institutional Study. July 24, 2024

Survival Patterns Based on First-site-specific Visceral Metastatic Prostate Cancer: Are Outcomes of Visceral Metastases the Same? July 24, 2024

NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis. July 24, 2024

Correlation analyses of radiographic progression-free survival with clinical and health-related quality of life outcomes in metastatic castration-resistant prostate cancer: Analysis of the phase 3 VISION trial. July 23, 2024

Association between pelvic lymph node dissection and survival among patients with prostate cancer treated with radical prostatectomy. July 23, 2024

Real-world evidence of 18F-fluciclovine Positron emission tomography/computed tomography performance for recurrent prostate cancer in the Veterans Affairs Health System. July 23, 2024

The Benefit of Combining Docetaxel with Androgen Deprivation Therapy in Localized and Metastatic Hormone-sensitive Prostate Cancer is Predicted by ERG Expression: An Analysis of Two GETUG Phase 3 Trials. July 23, 2024

Contemporary Treatment Patterns and Oncological Outcomes of Metastatic Hormone-sensitive Prostate Cancer and First- to Sixth- line Metastatic Castration-resistant Prostate Cancer Patients. July 23, 2024

A 2-year prospective evaluation of the Prostate Health Index in guiding biopsy decisions in a large cohort. July 23, 2024

Prostate Cancer Awareness in the Middle East: A Cross-Sectional International Study. July 23, 2024

Targeting androgen receptor degradation with PROTACs from bench to bedside. July 22, 2024

Discovery of a Series of Orally Bioavailable Androgen Receptor Degraders for the Treatment of Prostate Cancer. July 22, 2024

Comparison of synthesized and acquired high b-value diffusion-weighted MRI for detection of prostate cancer. July 22, 2024

61Cu-PSMA-Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging. July 22, 2024

Page 42 of 1450